Edition:
United States

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

53.60CHF
3:14am EST
Change (% chg)

CHF0.55 (+1.04%)
Prev Close
CHF53.05
Open
CHF53.05
Day's High
CHF53.85
Day's Low
CHF53.05
Volume
4,417
Avg. Vol
116,357
52-wk High
CHF59.40
52-wk Low
CHF38.98

BION.S

Chart for BION.S

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 1.21
Market Cap(Mil.): CHF2,994.37
Shares Outstanding(Mil.): 55.40
Dividend: 0.45
Yield (%): 5.37

Financials

  BION.S Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -4.95 -- --
ROI: -8.23 -1.09 14.95
ROE: -8.23 -2.39 16.29

BRIEF-BB Biotech Q3 profit of CHF 392.1 million

* Resulting profit for Q3 2016 is 392.1 million Swiss francs ($394.07 million) Source text for Eikon: Further company coverage: ($1 = 0.9950 Swiss francs) (Gdynia Newsroom)

Oct 21 2016

BRIEF-BB Biotech swings to prelim Q3 profit of CHF 392.1 mln

* Based on preliminary unaudited consolidated results, BB Biotech closed Q3 of 2016 with a profit of 392.1 million Swiss francs ($401.41 million)(575.4 million francs loss in corresponding period of previous year)

Oct 11 2016

BRIEF-BB Biotech reports 5.1 pct passive stake in Esperion Therapeutics

* BB Biotech AG reports 5.1 pct passive stake in Esperion Therapeutics as of September 22, 2016 - SEC filing Source text for Eikon: Further company coverage:

Sep 27 2016

BRIEF-BB Biotech Q2 net profit of CHF 36 mln

* Expects a return to growth from its portfolio holdings in coming quarters and for FY 2016 as a whole

Jul 22 2016

BRIEF-BB Biotech swings to H1 net loss of CHF 1.17 bln

* Based on preliminary unaudited consolidated results, BB Biotech AG closed first half year of 2016 with a loss of 1.17 billion Swiss francs ($1.19 billion)(717 million Swiss francs profit in corresponding period of previous year). Source text for Eikon: Further company coverage: ($1 = 0.9829 Swiss francs) (Gdynia Newsroom)

Jul 11 2016

Earnings vs. Estimates